Sort
16,300 grants matching “fatty liver disease”
A Multi-Level Intervention to Promote Healthy Beverage Intake through Childcare
$628,345Anisha Indravadan Patel · Stanford University · R01 · FY2022 · DK
Quantification of Liver Fibrosis with MRI and Deep Learning
$628,266Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · EB
Human population based genetic studies to elucidate the biology of NAFLD
$628,244Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Collaborative Clinical Research on Non Alcoholic Stratohepatitis
$628,215Naga P. Chalasani · Indiana University Indianapolis · U01 · FY2012 · DK
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$628,176Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Cellular origins and molecular mechanisms of arthrofibrosis
$628,174Denis Evseenko · University Of Southern California · R01 · FY2025 · AR
Sex-Specific Roles of L-PK in Cholesterol Metabolism and Atherosclerosis
$628,115Karthickeyan Chella Krishnan · University Of Cincinnati · R01 · FY2025 · HL
The role of Lamp1 and lipid transport in the regulation of vesicle identity
$627,674Andreas Jenny · Albert Einstein College Of Medicine · R01 · FY2024 · AG
Fully Automated High-Throughput Quantitative MRI of the Liver
$627,507Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2023 · EB
Molecular MR Imaging of Hepatic Fibrogenesis
$627,398Peter D Caravan · Massachusetts General Hospital · R01 · FY2021 · DK
Understanding the Multilevel Drivers of Liver Cancer Disparities
$627,382Salma Shariff-Marco · University Of California, San Francisco · R01 · FY2023 · CA
Fully Automated High-Throughput Quantitative MRI of the Liver
$627,116Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2022 · EB
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2021 · HL
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2023 · HL
Licensing LncRNAs in Atherosclerosis
$626,961Tamer Sallam · University Of California Los Angeles · R01 · FY2022 · HL
Quantifying Body Composition and Liver Disease in Children using Free-Breathing MRI and MRE
$626,823Holden H Wu · University Of California Los Angeles · R01 · FY2020 · DK
Development of caspase-6 inhibitors for treatment of NASH
$626,805Alan R. Saltiel · University Of California, San Diego · R01 · FY2025 · DK
Hormonal Regulation of Fat Deposition
$626,650Jonathan M Graff · Ut Southwestern Medical Center · R01 · FY2010 · DK
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
$626,624Robert Clayton Bauer · Columbia University Health Sciences · R01 · FY2023 · DK
A Dietary Intervention to Improve Glucose Tolerance in Adults with Cystic Fibrosis
$626,525Jessica Alejandra Alvarez · Emory University · R01 · FY2024 · DK
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$626,492Brian Jesse Debosch · Washington University · R01 · FY2023 · HL
Biology of the orphan receptor Rev-erb alpha
$626,292Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2011 · DK
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer
$626,197Andrew T Chan · Massachusetts General Hospital · R01 · FY2021 · CA
Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring
$626,155Teri L Hernandez · University Of Colorado Denver · R01 · FY2014 · DK
Cutaneous biomarkers of pediatric non-alcoholic fatty liver disease
$626,121Marialena Mouzaki · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · DK